15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Afya Ltd, 0 rate it Buy or better, 4 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $14.00 to $21.00, a moderate spread. The average target of $16.80 sits 18% above the current $14.22. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 8% this year and 7% next, consensus EPS building from about $2.02 next quarter toward $10.21 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy00%
Hold480%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Afya Ltd.
As of Jul, 0 of 4 firms rate AFYA a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
AFYA EPS & revenue forecast
EPS · NEXT QUARTER
$2.02
Range $1.69 – $2.35 · 4 analysts · -3% YoY
Next period, 4 analysts expect Afya Ltd to earn $2.02 a share (range $1.69 – $2.35), versus $2.08 a year earlier. Full-year consensus is $9.30, growing to $10.21 the year after.
REVENUE · NEXT QUARTER
$1.0B
Range $1.0B – $1.0B · 4 analysts · +9% YoY
Revenue is expected to reach $1.0B (range $1.0B – $1.0B), +9.0% year-over-year. Full-year consensus is $4.0B, rising to $4.3B next year.
Top analysts covering Afya Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AFYA.
#1
MS
Marcelo Santos
JP Morgan
Hold
$21.00+47.7% to target
Coverage
—
+ Follow
#2
AS
Andre Salles
UBS
Hold
$16.00+12.5% to target
Coverage
—
+ Follow
#3
LB
Leandro Bastos
Citigroup
Hold
$14.00-1.5% to target
Coverage
—
+ Follow
#4
MC
Mauricio Cepeda
Morgan Stanley
Sell
$16.00+12.5% to target
Coverage
—
+ Follow
#5
RO
Roberto Otero
B of A Securities
Hold
$17.00+19.5% to target
Coverage
—
+ Follow
AFYA stock forecast FAQ
What is AFYA's average 12-month price target?+
The 5 analysts with a live target average $16.80 for Afya Ltd over the next 12 months, ranging from a $21.00 high to a $14.00 low.
Is AFYA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 0 are Buy or Strong Buy, 4 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for AFYA?+
The Street-high target is $21.00 (JP Morgan), and the Street-low is $14.00 (Citigroup). The average of all 5 active targets is $16.80.
How many Wall Street analysts cover AFYA?+
5 analysts have an active rating on Afya Ltd, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering AFYA?+
Among analysts who currently cover AFYA, Marcelo Santos of JP Morgan has the strongest overall Quantellect track record. Their current call is Hold with a $21.00 target.
What is Afya Ltd's projected EPS for next quarter?+
The consensus estimate is $2.02 per share (range $1.69 – $2.35) across 4 analysts. Full-year EPS is projected at $9.30, rising to $10.21 the following year.
How much revenue is Afya Ltd expected to report next quarter?+
Consensus revenue is $1.0B (range $1.0B – $1.0B). Full-year revenue is projected at $4.0B, growing to $4.3B next year.
Have analysts been upgrading or downgrading AFYA lately?+
As of Jul, 0 of 4 firms rate AFYA a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AFYA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
